[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"$f65-g5LTUgHIk8dGZIHhGe2pKpxnfW0g-O4HGxk3yxcs":3,"$fSXgUnWsF7XfCOZ2edw-V0CJdP2ICbj1Peguzw8XjeiU":8,"$fFF0xaqSES-9fQ0Cwl6lIHdb167FFkARg5pNeH_yF3X4":55,"$f8itf14RfLQowxo9ISu1E0240vbZN5SXT2jJ7X3BFknk":59},{"code":4,"msg":5,"message":6,"data":6,"success":7},401,"认证失败，无法访问系统资源",null,false,{"code":9,"msg":10,"message":6,"data":11,"success":54},200,"操作成功",{"id":12,"specialistId":13,"specialistAssistants":14,"profilePhoto":15,"specialistName":16,"hospital":17,"department":18,"postsTitle":19,"materialTotal":20,"videoTotal":21,"isConcern":7,"title":22,"coverVertical":23,"coverAcross":24,"content":25,"description":26,"views":27,"likes":21,"isThumbsUp":7,"isCollection":7,"collections":21,"createTime":28,"seoTitle":22,"seoKeywords":29,"seoDescription":30,"shelvesTime":31,"version":32,"menus":33,"menuId":35,"type":42,"quality":53,"commentCount":21,"isComment":42},60628,868808,[],"https://cdn.haohuanjiao.com/learnMaterial/ystApp//iTCP1DSvplAFJhNCT6SR8jINhAgp8TZa.png","王凯来","浙江大学医学院附属第二医院","肿瘤科","住院医师",20,0,"直肠癌与乙状结肠癌常用药品全攻略：聚焦替雷利珠单抗、贝伐珠单抗及XELOX化疗的用药细节","","https://ystcdn.venuertc.com/venue/AI/04c4e639-e1f2-4bc0-9f7d-21231476ef66.jpg","\u003Cdiv class=\"drug-guide-outer-container\">\n  \u003Cdiv class=\"drug-guide-title-wrap\">\n    \u003Ch1 id=\"material_title\" class=\"drug-guide-main-title\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">直肠癌与乙状结肠癌常用药品全攻略：聚焦替雷利珠单抗、贝伐珠单抗及XELOX化疗的用药细节\u003C/h1>\n    \u003Cdiv class=\"drug-guide-title-desc\">本指南将围绕替雷利珠单抗、贝伐珠单抗和XELOX方案（奥沙利铂+卡培他滨）这三类结直肠常用抗肿瘤药品，深入讲解9个实用用药细节。让我们一起弄懂这些药物的正确使用方式、牢记各项安全注意点，帮助您和家人合理用药，规避风险。\u003C/div>\n  \u003C/div>\n\n  \u003Cdiv class=\"drug-guide-section-box\">\n    \u003Ch2 class=\"drug-guide-section-title\" style=\"background: linear-gradient(90deg, rgb(232, 243, 254) 0%, rgb(250, 252, 251) 100%); color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">01 替雷利珠单抗：用药方法和时间要点 🕒\u003C/h2>\n    \u003Cdiv class=\"drug-guide-section-text\">\n      替雷利珠单抗是一种静脉注射的免疫检查点抑制剂，用于特定人群的抗肿瘤治疗。\u003Cbr>\n      \u003Cstrong>使用方式：\u003C/strong>\n      \u003Cul>\n        \u003Cli>每3周静脉滴注1次，根据体重调整剂量（通常200mg一次），由专业医务人员在医院配制和给药。\u003C/li>\n        \u003Cli>整个输注时间需控制在60分钟左右，不能推注或静脉注射。\u003C/li>\n      \u003C/ul>\n      \u003Cstrong>正确做法：\u003C/strong> 治疗间隔期间不能擅自提前或推迟，许运输及存储温度需严格控制，配制后应短期内用完。如有特殊反应请立即告知医护人员。\u003Cbr>\n      \u003Cspan class=\"drug-guide-tip\">需在专业医院实施，切勿自行注射。\u003C/span>\n    \u003C/div>\n  \u003C/div>\n\n  \u003Cdiv class=\"drug-guide-section-box\">\n    \u003Ch2 class=\"drug-guide-section-title\" style=\"background: linear-gradient(90deg, rgb(253, 255, 245) 0%, rgb(242, 244, 250) 100%); color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">02 贝伐珠单抗：剂量调整与静脉给药规范 💧\u003C/h2>\n    \u003Cdiv class=\"drug-guide-section-text\">\n      贝伐珠单抗是一种靶向抗肿瘤药物，只能静脉滴注，不可肌注或口服。\u003Cbr>\n      \u003Cstrong>正确用法：\u003C/strong>\n      \u003Cul>\n        \u003Cli>首次输注通常为90分钟，若无不良反应后续可尝试60分钟，最短不小于30分钟。\u003C/li>\n        \u003Cli>药物需根据体重（5 mg/kg或7.5 mg/kg）精确计算后，由护士配制注射。\u003C/li>\n      \u003C/ul>\n      \u003Cstrong>注射期间：\u003C/strong> 应严格监测血压和有无过敏反应。贝伐珠单抗忌与氨基糖苷类、头孢类某些抗生素同瓶混合。\u003Cbr>\n      \u003Cspan class=\"drug-guide-tip\">家有患者时，不要私自减少剂量或随意调整治疗间隔。\u003C/span>\n    \u003C/div>\n  \u003C/div>\n\n  \u003Cdiv class=\"drug-guide-section-box\">\n    \u003Ch2 class=\"drug-guide-section-title\" style=\"background: linear-gradient(90deg, rgb(250, 248, 251) 0%, rgb(242, 250, 249) 100%); color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">03 XELOX方案中的卡培他滨：口服注意事项 🍽️\u003C/h2>\n    \u003Cdiv class=\"drug-guide-section-text\">\n      XELOX方案包括奥沙利铂和卡培他滨，后者为口服药物。\u003Cbr>\n      \u003Cstrong>卡培他滨服用要点：\u003C/strong>\n      \u003Cul>\n        \u003Cli>建议在饭后30分钟内用200ml温开水送服，切忌空腹或用茶、牛奶、果汁送药。\u003C/li>\n        \u003Cli>每日两次，早晚间隔约12小时，连续服用2周后停药1周为1周期。\u003C/li>\n      \u003C/ul>\n      \u003Cstrong>服用过程：\u003C/strong> 若服药后出现呕吐，不建议补服，要等下次按计划服用。\u003Cbr>\n      \u003Cspan class=\"drug-guide-tip\">卡培他滨片不能掰碎或嚼服。\u003C/span>\n      \u003Cbr>\n      \u003Cstrong>案例分享：\u003C/strong>\n      \u003Cdiv class=\"drug-guide-case-box\">\n        一位44岁男性在按周期服用卡培他滨片时，坚持餐后服用并未自行调整周期，未出现严重不良反应，说明规律服药带来的好处。\n      \u003C/div>\n    \u003C/div>\n  \u003C/div>\n\n  \u003Cdiv class=\"drug-guide-section-box\">\n    \u003Ch2 class=\"drug-guide-section-title\" style=\"background: linear-gradient(90deg, rgb(245, 251, 244) 0%, rgb(250, 246, 250) 100%); color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">04 XELOX方案中的奥沙利铂：输注和皮肤防护 🌡️\u003C/h2>\n    \u003Cdiv class=\"drug-guide-section-text\">\n      奥沙利铂只适合静脉滴注，使用时有几个关键点：\n      \u003Cul>\n        \u003Cli>必须稀释于葡萄糖溶液中，禁止用氯化钠溶液配制，以避免药物失效。\u003C/li>\n        \u003Cli>输注通常持续2小时，如中途发生刺痛、红肿或水泡等皮肤异常，应立即停药处理。\u003C/li>\n        \u003Cli>用药期间和后期，需避免暴露于寒冷环境，比如避免直接接触冰水、冷饮和冷空气。\u003C/li>\n      \u003C/ul>\n      \u003Cspan class=\"drug-guide-tip\">若发现针眼处异常，如红肿、硬结，应立即报告护士，不要自行处理。\u003C/span>\n    \u003C/div>\n  \u003C/div>\n\n  \u003Cdiv class=\"drug-guide-section-box\">\n    \u003Ch2 class=\"drug-guide-section-title\" style=\"background: linear-gradient(90deg, rgb(247, 252, 250) 0%, rgb(249, 249, 250) 100%); color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">05 常见不良反应的识别和处理 🚩\u003C/h2>\n    \u003Cdiv class=\"drug-guide-section-text\">\n      每种药物的不良反应有差异，及时识别和处理很重要。\n      \u003Cul>\n        \u003Cli>\u003Cstrong>替雷利珠单抗：\u003C/strong> 可能引起免疫相关不良事件，比如皮疹、乏力，偶见肺部和肝脏损害。发现皮肤瘙痒、黄疸等特殊表现需尽快报告医生。\u003C/li>\n        \u003Cli>\u003Cstrong>贝伐珠单抗：\u003C/strong> 普遍见到的副作用为高血压、蛋白尿，极少数可引起出血、伤口愈合不良。如遇头疼、眼花或尿中泡沫增多应去医院评估。\u003C/li>\n        \u003Cli>\u003Cstrong>卡培他滨及奥沙利铂：\u003C/strong> 可能导致手足红肿或麻木、轻度肠胃不适。手脚干裂或感觉异常时应减少摩擦，可使用保湿霜保护皮肤。\u003C/li>\n      \u003C/ul>\n      \u003Cspan class=\"drug-guide-tip\">发生严重不适时，不要自行停药或加大剂量，应联系医务人员。\u003C/span>\n      \u003Cbr>\n      \u003Cstrong>数据参考：\u003C/strong> 临床数据显示，XELOX方案整体严重不良反应发生率小于10%\u003Cspan class=\"drug-guide-ref\">（Benson et al., 2019）\u003C/span>。\n    \u003C/div>\n  \u003C/div>\n\n  \u003Cdiv class=\"drug-guide-section-box\">\n    \u003Ch2 class=\"drug-guide-section-title\" style=\"background: linear-gradient(90deg, rgb(246, 248, 253) 0%, rgb(250, 249, 249) 100%); color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">06 药物相互作用全解 🎯\u003C/h2>\n    \u003Cdiv class=\"drug-guide-section-text\">\n      不同药物之间可能会增强副作用、影响疗效。以及和食物的关系也不能忽视。\n      \u003Cul>\n        \u003Cli>\u003Cstrong>替雷利珠单抗：\u003C/strong> 目前未发现与常规化疗药物严重相互作用，但免疫抑制剂合用需谨慎。\u003C/li>\n        \u003Cli>\u003Cstrong>贝伐珠单抗：\u003C/strong> 不建议与抗血小板药、抗凝药（如阿司匹林、华法林）同时使用，因有增加出血风险。\u003C/li>\n        \u003Cli>\u003Cstrong>卡培他滨：\u003C/strong> 避免与华法林、高剂量维生素K、苯妥英等药物联合应用。\u003C/li>\n        \u003Cli>\u003Cstrong>奥沙利铂：\u003C/strong> 与氯化钠溶液混合会使药品失活，不能与其他药品直接兼容滴注。\u003C/li>\n      \u003C/ul>\n      \u003Cspan class=\"drug-guide-tip\">如需长期多药合用，务必主动向医生说明所有药品名称。\u003C/span>\n    \u003C/div>\n  \u003C/div>\n\n  \u003Cdiv class=\"drug-guide-section-box\">\n    \u003Ch2 class=\"drug-guide-section-title\" style=\"background: linear-gradient(90deg, rgb(243, 252, 250) 0%, rgb(251, 250, 248) 100%); color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">07 特殊人群用药要求 👶👴\u003C/h2>\n    \u003Cdiv class=\"drug-guide-section-text\">\n      \u003Cul>\n        \u003Cli>\u003Cstrong>老年人：\u003C/strong> 由于肝肾功能下降，替雷利珠单抗、卡培他滨等药需根据情况调整剂量并严密监测。\u003C/li>\n        \u003Cli>\u003Cstrong>肝肾功能障碍者：\u003C/strong> 卡培他滨、奥沙利铂等代谢依赖肝肾的药物，应在医生指导下按实际情况减量。\u003C/li>\n        \u003Cli>\u003Cstrong>孕妇、哺乳期：\u003C/strong> 贝伐珠单抗及XELOX方案都不建议妊娠或哺乳期使用。\u003C/li>\n        \u003Cli>\u003Cstrong>儿童：\u003C/strong> 目前结直肠相关化疗/靶向方案尚无儿童标准剂量，仅限特殊医师指导。\u003C/li>\n      \u003C/ul>\n      \u003Cspan class=\"drug-guide-tip\">用药前务必告知医生全部既往用药和基础疾病。\u003C/span>\n    \u003C/div>\n  \u003C/div>\n\n  \u003Cdiv class=\"drug-guide-section-box\">\n    \u003Ch2 class=\"drug-guide-section-title\" style=\"background: linear-gradient(90deg, rgb(254, 252, 252) 0%, rgb(244, 250, 254) 100%); color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">08 储存、配制及剩余药品处理建议 🗄️\u003C/h2>\n    \u003Cdiv class=\"drug-guide-section-text\">\n      药品存放以及开封后的处理同样关键。\u003Cbr>\n      \u003Cul>\n        \u003Cli>\u003Cstrong>替雷利珠单抗与贝伐珠单抗：\u003C/strong> 应于2~8℃冷藏，切勿冷冻。使用前配制，剩余溶液须于8小时内用完，过期废弃。\u003C/li>\n        \u003Cli>\u003Cstrong>卡培他滨：\u003C/strong> 避免高温、潮湿，常温（25℃以下）避光储存，开瓶后务必盖紧。\u003C/li>\n        \u003Cli>\u003Cstrong>奥沙利铂：\u003C/strong> 未稀释原液储存于2~8℃，稀释后限4~12小时内使用。\u003C/li>\n      \u003C/ul>\n      \u003Cspan class=\"drug-guide-tip\">如有药品变色、析出、气味异常请勿继续服用。\u003C/span>\n    \u003C/div>\n  \u003C/div>\n\n  \u003Cdiv class=\"drug-guide-section-box\">\n    \u003Ch2 class=\"drug-guide-section-title\" style=\"background: linear-gradient(90deg, rgb(247, 254, 254) 0%, rgb(255, 247, 246) 100%); color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">09 漏服与用量过多时的正确处理步骤 🆘\u003C/h2>\n    \u003Cdiv class=\"drug-guide-section-text\">\n      \u003Cul>\n        \u003Cli>\u003Cstrong>替雷利珠单抗、贝伐珠单抗：\u003C/strong> 假如漏用一剂，及时与医生联系，切勿自行补打。\u003C/li>\n        \u003Cli>\u003Cstrong>卡培他滨：\u003C/strong> 忘记吃药时，应略过漏服那次，下一剂照常，不可一次服双倍剂量。\u003C/li>\n        \u003Cli>\u003Cstrong>奥沙利铂：\u003C/strong> 因需医院静脉注射，漏用应由医院安排补做，不应私自调整。\u003C/li>\n      \u003C/ul>\n      \u003Cspan class=\"drug-guide-tip\">如用药过量或意外二次服用，应立即前往医院监测和处理。\u003C/span>\n      \u003Cbr>\n      \u003Cstrong>真实案例：\u003C/strong>\n      \u003Cdiv class=\"drug-guide-case-box\">\n        有患者因漏服卡培他滨后自作主张双倍补服，导致短期内手足综合征症状加重，明确提示按时规律服药的重要性。\n      \u003C/div>\n    \u003C/div>\n  \u003C/div>\n\n  \u003Cdiv class=\"drug-guide-summary-wrap\">\n    \u003Ch2 class=\"drug-guide-summary-title\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">总结及用药建议 🌟\u003C/h2>\n    \u003Cdiv class=\"drug-guide-summary-text\">\n      三大常用药物（替雷利珠单抗、贝伐珠单抗、XELOX方案）各有专属用药规则。无论口服还是注射，每一个环节都要规范操作。特别注意药品储存、服药时间、漏服补救、合理调整剂量，并密切关注可能的不良反应。安全用药的最大保障就是\u003Cstrong>不擅自更换方案、不随意增减剂量、遇问题立即问医生\u003C/strong>。记住这些要点，既保证了药效，也大幅降低风险。\n    \u003C/div>\n  \u003C/div>\n  \n  \u003Cdiv class=\"drug-guide-ref-list\">\n    \u003Ch3 class=\"drug-guide-ref-title\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">引用文献\u003C/h3>\n    \u003Cul>\n      \u003Cli>Benson, A.B., Venook, A.P., Al-Hawary, M.M., et al. (2019). NCCN Guidelines Insights: Colon Cancer, Version 2.2018. \u003Cem>Journal of the National Comprehensive Cancer Network\u003C/em>, 17(3), 239-246. https://doi.org/10.6004/jnccn.2019.0011\u003C/li>\n      \u003Cli>Amin, M.B., Edge, S.B., Greene, F.L., et al. (2017). AJCC Cancer Staging Manual (8th ed.). Springer International Publishing.\u003C/li>\n      \u003Cli>Hurwitz, H., Fehrenbacher, L., Novotny, W., et al. (2004). Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer. \u003Cem>New England Journal of Medicine\u003C/em>, 350(23), 2335-2342. https://doi.org/10.1056/NEJMoa032691\u003C/li>\n      \u003Cli>Miao, D., Margolis, C.A., Gao, W., et al. (2017). Genomic correlates of response to immune checkpoint therapies in microsatellite-stable colorectal cancer. \u003Cem>Science\u003C/em>, 357(6347), 409-413. https://doi.org/10.1126/science.aan6733\u003C/li>\n    \u003C/ul>\n  \u003C/div>\n\u003C/div>\n\n\u003Cstyle>\n.drug-guide-outer-container {\n  max-width: 814px;\n  margin: 38px auto 48px auto;\n  padding: 24px 18px 30px 18px;\n  background: #f7fafd;\n  border-radius: 16px;\n  box-shadow: 0 2px 14px 0 rgba(145,180,220,0.09);\n  font-family: \"PingFang SC\", \"Microsoft YaHei\", Arial, sans-serif;\n}\n\n.drug-guide-title-wrap {\n  padding-bottom: 12px;\n  border-bottom: 2px solid #e4ecf5;\n  margin-bottom: 20px;\n}\n.drug-guide-main-title {\n  color: #274587;\n  font-size: 1.9em;\n  font-weight: bold;\n  line-height: 1.3;\n  margin: 0 0 8px 0;\n  font-family: \"PingFang SC\", \"Microsoft YaHei\", Arial, sans-serif;\n}\n.drug-guide-title-desc {\n  color: #536072;\n  font-size: 1.12em;\n  margin-top: 2px;\n  margin-bottom: 4px;\n  letter-spacing: 0.02em;\n  line-height: 1.68;\n}\n\n.drug-guide-section-box {\n  margin: 36px 0 26px 0;\n  background: #ffffff;\n  padding: 22px 18px 22px 24px;\n  border-radius: 14px;\n  box-shadow: 0 1px 7px 0 rgba(100, 140, 170, 0.04);\n}\n\n.drug-guide-section-title {\n  font-size: 1.25em;\n  color: #185073;\n  font-weight: 600;\n  margin-top: 0;\n  margin-bottom: 14px;\n  padding: 14px 14px 14px 10px;\n  border-radius: 8px 8px 8px 8px;\n  background-position: right top;\n  background-size: cover;\n  letter-spacing: 0.04em;\n  position: relative;\n  z-index: 1;\n}\n\n.drug-guide-section-text {\n  color: #23405A;\n  font-size: 1.07em;\n  line-height: 1.85;\n  padding: 4px 0 0 2px;\n  word-break: break-all;\n}\n\n.drug-guide-section-text ul {\n  margin: 10px 0 10px 12px;\n  padding-left: 18px;\n}\n\n.drug-guide-tip {\n  display: inline-block;\n  color: #268f72;\n  background: linear-gradient(90deg,#f5fdfa 60%, #faffe2 100%);\n  font-size: 1em;\n  padding: 4px 10px;\n  border-radius: 6px;\n  margin-top: 5px;\n  font-weight: 500;\n  margin-left: 0;\n}\n\n.drug-guide-case-box {\n  border-left: 4px solid #89b1e0;\n  background: #f6fafd;\n  padding: 8px 16px;\n  margin-top: 10px;\n  font-size: 0.98em;\n  color: #286470;\n}\n\n.drug-guide-summary-wrap {\n  margin: 30px 0 22px 0;\n  padding: 18px 15px;\n  background: linear-gradient(90deg,#fdfbfb 0%, #eaf2fb 100%);\n  border-radius: 10px;\n}\n.drug-guide-summary-title {\n  font-size: 1.1em;\n  color: #206298;\n  font-weight: bold;\n  margin-bottom: 11px;\n}\n.drug-guide-summary-text {\n  color: #273142;\n  font-size: 1.08em;\n  line-height: 1.74;\n  letter-spacing: 0.02em;\n}\n\n.drug-guide-ref-list {\n  margin: 14px 4px 0 6px;\n  padding-top: 8px;\n  background: #f7fafb;\n  border-radius: 6px;\n}\n.drug-guide-ref-title {\n  color: #868da1;\n  font-size: 1.04em;\n  font-weight: 600;\n  margin: 0 0 6px 0;\n}\n.drug-guide-ref-list ul {\n  padding-left: 22px;\n  margin: 2px 0 2px 0;\n  color: #3a4f54;\n  font-size: 0.99em;\n}\n.drug-guide-ref {\n  color: #90b0d0;\n  font-size: 0.97em;\n}\n\n@media only screen and (max-width: 620px) {\n  .drug-guide-outer-container {\n    padding: 9px 2vw 14px 2vw;\n    box-shadow: none;\n    border-radius: 0;\n  }\n  .drug-guide-section-box {\n    padding-left: 3vw;\n    padding-right: 2vw;\n  }\n  .drug-guide-summary-wrap {\n    padding-left: 2vw;\n    padding-right: 2vw;\n  }\n}\n\u003C/style>\n","\u003Cdiv class=\"drug-guide-outer-container\">\n  \u003Cdiv class=\"drug-guide-title-wrap\">\n    \u003Ch1 id=\"material_",529,"2025-08-19 16:34:03","直肠癌, 乙状结肠癌, 替雷利珠单抗, 贝伐珠单抗, XELOX","本指南提供了替雷利珠单抗、贝伐珠单抗及XELOX方案的详细用药信息，帮助患者和家属掌握正确用药方法与安全注意点，有效规避风险并优化治疗效果。","2025-08-20 07:08:00",2,[34],{"menuId":35,"menuName":36,"parentId":21,"orderNum":32,"path":37,"component":38,"isFrame":39,"isCache":40,"menuType":41,"visible":42,"status":21,"createDept":6,"remark":23,"createTime":43,"children":44,"columnImage":45,"columnLogo":46,"uncheckedLogo":6,"checkedLogo":6,"isHot":42,"isHome":21,"forceLogin":21,"color":47,"seoTitle":48,"seoKeywords":49,"seoDescription":50,"contentNum":6,"promotionalPoster":51,"menuFrame":7,"innerLink":7,"parentView":7,"routeName":52,"routerPath":37,"componentInfo":38},"1986713082609147906","健康科普","article","/article.html","1","0","T",1,"2025-11-07 16:31:25",[],"https://ystcdn.venuertc.com/venue/undefined/2026-01-24-18:08:49/d4291d16-ed1c-48dd-84c8-ec1f85980b75.png","https://ystcdn.venuertc.com/venue/undefined/2026-01-24-18:08:52/6fe64094-9416-442c-a66d-032fb292666a.png","#c8e6ca","健康科普助力健康中国2030:共享健康知识新理念","健康科普, 健康中国, 科普知识, 健康家庭, 性健康, 营养健康, 运动健康, 科普宣传","探索健康科普在健康中国行动中的重要角色,了解最新的健康科普创新大赛、动漫及短视频,传播健康知识,助力全民健康。","https://ystcdn.venuertc.com/venue/undefined/2026-01-24-18:08:56/bd33f471-6c54-4d1b-a364-b06973dbc144.png","Article","癌症肿瘤,重大疾病",true,{"code":9,"msg":10,"message":6,"data":56,"success":54},{"pageNo":42,"pageSize":57,"result":58,"totalSize":21},10,[],{"code":9,"msg":10,"message":6,"data":60,"success":54},{"authors":61,"appraiseDimensionScoresVos":62},[],[]]